---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-003380"
form_type: "8-K"
ticker: "SLNO"
cik: "0001484565"
company_name: "SOLENO THERAPEUTICS INC"
filed_at: "2024-01-05T23:59:59+00:00"
generated_at: "2026-06-07T03:03:58.445525+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Soleno Therapeutics sets 2024 executive compensation: CEO salary $640K, bonus $500K, equity grants

## Summary
- CEO Bhatnagar 2024 salary $640K, 2023 bonus $500K, equity: 100K options (50% cliff 1yr) + 150K RSUs (quarterly vest).
- CFO Mackaness salary $460K, bonus $240K, equity: 37K options + 56K RSUs.
- VP Regulatory Hirano salary $375K, bonus $153K, equity: 16K options + 24K RSUs.
- Salary increases effective Jan 1, 2024; bonuses for FY2023.
- Options vest 50% on first anniversary, then monthly; RSUs vest quarterly in 2024.

## SEC filing metadata
- accession: 0001193125-24-003380
- form_type: 8-K
- ticker: SLNO
- cik: 0001484565
- company_name: SOLENO THERAPEUTICS INC
- filed_at: 2024-01-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484565/000119312524003380/0001193125-24-003380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484565/000119312524003380/d111987d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-003380
- JSON: https://secwatch.observer/filing/0001193125-24-003380.json
- Plain text: https://secwatch.observer/filing/0001193125-24-003380.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.